Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BVD in Elderly Relapsed/Refractory Multiple Myeloma
NCT01045681Phase 2Completed
- Start
- Mar 2010
- Primary completion
- Mar 2013
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine, bortezomib in multiple myeloma (MM). Started Mar 2010; status: completed.
02
Drugs
bendamustinebortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01045681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01045681.